RBM22 and colorectal cancer: Interestingly, cleaved PARP was augmented by the downregulation of RBM22 and U2AF1, suggesting that RBM22 and U2AF1 inhibited apoptosis and promoted the tumor progression in colorectal cancer cells through cyclin B1 and/or cyclin D1-dissociated mechanisms.